562 related articles for article (PubMed ID: 21549923)
1. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
J Cardiothorac Surg; 2011 May; 6():69. PubMed ID: 21569412
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model.
Liu K; Cao G; Zhang X; Liu R; Zou W; Wu S
Int J Nanomedicine; 2010 Oct; 5():853-60. PubMed ID: 21042547
[TBL] [Abstract][Full Text] [Related]
4. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
[TBL] [Abstract][Full Text] [Related]
5. Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis.
Shi X; Chen G; Guo LW; Si Y; Zhu M; Pilla S; Liu B; Gong S; Kent KC
PLoS One; 2014; 9(2):e89227. PubMed ID: 24586612
[TBL] [Abstract][Full Text] [Related]
6. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
[TBL] [Abstract][Full Text] [Related]
7. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
[TBL] [Abstract][Full Text] [Related]
8. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
10. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
11. [Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts].
Qiu XF; Dong NG; Sun ZQ; Hu P; Su W; Shi JW
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2938-42. PubMed ID: 20137655
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-145-loaded poly(lactic-co-glycolic acid) nanoparticles attenuate venous intimal hyperplasia in a rabbit model.
Nishio H; Masumoto H; Sakamoto K; Yamazaki K; Ikeda T; Minatoya K
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2242-2251. PubMed ID: 30447962
[TBL] [Abstract][Full Text] [Related]
13. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
14. [Effect of gene transfer using nanoparticles as gene vector in different animal models].
Yang J; Song CX; Li YJ; Guan H; Li DY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):475-80. PubMed ID: 16995296
[TBL] [Abstract][Full Text] [Related]
15. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
[TBL] [Abstract][Full Text] [Related]
16. Effect of external stenting and systemic hypertension on intimal hyperplasia in rat vein grafts.
Meguro T; Nakashima H; Kawada S; Tokunaga K; Ohmoto T
Neurosurgery; 2000 Apr; 46(4):963-9; discussion 969-70. PubMed ID: 10764272
[TBL] [Abstract][Full Text] [Related]
17. Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.
Tsihlis ND; Murar J; Kapadia MR; Ahanchi SS; Oustwani CS; Saavedra JE; Keefer LK; Kibbe MR
J Vasc Surg; 2010 May; 51(5):1248-59. PubMed ID: 20223627
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling 3 is a negative regulator for neointimal hyperplasia of vein graft stenosis.
Xiang S; Liu J; Dong N; Shi J; Xiao Y; Wang Y; Hu X; Gong L; Wang W
J Vasc Res; 2014; 51(2):132-43. PubMed ID: 24685947
[TBL] [Abstract][Full Text] [Related]
19. Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation.
Kimura S; Egashira K; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Kawashima Y; Tominaga R; Sunagawa K
Circulation; 2008 Sep; 118(14 Suppl):S65-70. PubMed ID: 18824771
[TBL] [Abstract][Full Text] [Related]
20. Employing the Sirolimus-Eluting Poly (Propylene Carbonate) Mesh for the Prevention of Arteriovenous Graft Stenosis in Rats.
Sun H; Liu CZ; Liu C; Tang M; Cao G; Zhang Q; Gu X
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):269-277. PubMed ID: 30474386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
